A promising avenue for certain composites: banana fiber. 2025 EPFL/Alain Herzog - CC-BY-SA 4.0 Researchers at EPFL and its ...

Plants produce an enormous abundance of natural products. Many natural plant products are ancestry-specific and occur only in ...

Roche, along with Bristol Myers Squibb, Novo Nordisk, AbbVie, Eli Lilly and others, is making inroads into molecular glues to use in cancer, immunology and other applications.

Most widely used adhesives are toxic and derived from petroleum, but researchers have come up with a safe, recyclable ...

Roche's Genentech is sticking with Orionis Biosciences, handing over $105 million upfront as part of its second deal with the molecular glue biotech. The latest multiyear collaboration will be ...

BMS signs $674M biobucks pact with Roivant-backed VantAI for molecular glues In late 2023, after SK Pharmaceuticals acquired a 60% stake in Proteovant , Blueprint completely redid the agreement ...

Ben Hargreaves investigates why molecular glues are seeing greater levels of investment, and how they could provide treatments for a broad range of conditions. Molecular glues are types of ...

This integration facilitates the generation and analysis of in-cell protein interaction events, propelling the discovery and design of molecular glues to address challenging disease targets.

New research from Max Planck Institute reveals how plants defend their genomes from invasion by chloroplast DNA.

Roche’s Genentech unit will pay privately held Orionis Biosciences $105 million to kick off a second joint effort to develop molecular glues, this time with an exclusive focus on cancer.

This study, which reveals for the first time the molecular basis of auxin import mediated by the AUX1/LAX protein family in plants, represents an important breakthrough in understanding plant ...